Close Menu

gene editing

NEW YORK (GenomeWeb News) – Genome-wide association studies have in recent years turned up a number of genetic variants that may contribute to the risk of late-onset Alzheimer's disease, and now the National Institute on Aging plans to fund efforts to further investigate the functional relationsh

NEW YORK (GenomeWeb News) – Gene editing firm Recombinetics today said that it surpassed its $2 million fundraising goal this month.
The St. Paul, Minn.-based firm did not disclose its investors.

NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed certain genetic engineering patents from Life Technologies and Sigma-Aldrich, which the Madison, Wis.-based firm will use in creating human disease models and isogenic controls.

NEW YORK (GenomeWeb News) – Precision BioSciences said today that it is suing Lonza Group and a number of its affiliates for patent infringement.

NEW YORK (GenomeWeb News) – Life Technologies today announced the launch of a sublicensing program for technology covering nucleic acids encoding Transcription Activator-Like Effector Nuclease fusion proteins, or TALENS, one month after a patent for the technology was issued.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has signed an agreement to serve as worldwide distributor of Olink Bioscience's Duolink In Situ products.

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has established a Center of Excellence at Washington University in St. Louis.

NEW YORK (GenomeWeb News) – Horizon Discovery and H3 Biomedicine today launched SyntheTx, a technology partnership created to provide novel oncology targets and early-stage drug discovery programs to drug manufacturers.

NEW YORK (GenomeWeb News) – Horizon Discovery and biopharmaceutical firm H3 Biomedicine today announced a collaboration to identify and validate a panel of novel cancer drug targets.

Pages

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.